| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-10 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-09 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.23 | 2e-09 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-09 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-09 |